Financial news, mergers and acquisitions, partnerships, and alliances.
Cigna is the first national private payor to provider coverage for the Decipher tests, which provide a genomic assessment of tumor aggressiveness.
The collaboration will give the company access to UCI research in diagnostic platforms, life science applications, devices, and data analytics.
A new company will be established to develop a service platform using blockchain technology for medical services and personalized health management.
The Belgian cancer center plans to evaluate Natera's ctDNA assay for evaluating response and detecting minimal residual disease in breast cancer patients.
Under a definitive merger agreement, Roche will acquire outstanding shares of Foundation's common stock for $137 per share.